T. Rowe Price Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $854K | Buy |
|
|||||
|
2025
Q1 | $1.04M | Hold |
|
|||||
|
2024
Q4 | $1.52M | Sell |
|
|||||
|
2024
Q3 | $86.1M | Sell |
|
|||||
|
2024
Q2 | $155M | Sell |
|
|||||
|
2024
Q1 | $271M | Sell |
|
|||||
|
2023
Q4 | $377M | Sell |
|
|||||
|
2023
Q3 | $248M | Buy |
|
|||||
|
2023
Q2 | $514M | Sell |
|
|||||
|
2023
Q1 | $380M | Sell |
|
|||||
|
2022
Q4 | $302M | Buy |
|
|||||
|
2022
Q3 | $377M | Buy |
|